Long Survival (Cure) to Cisplatin/Infusional 5-Flurouracil in Metastatic Squamous Cell Anal Cancer with Extensive Liver and Lung Metastases


Background: Metastatic anal Squamous Cell Carcinoma (SCC) is a relatively uncommon malignancy that is usually treated with palliative platinum based chemotherapy. Response rates are modest and complete responses are rare. Case Report: Here we report on a case of advanced SCC with the extensive visceral metastatic disease that has possibly been cured with chemotherapy alone. The patient has received 6 cycles of Cisplatin and 5FU and has remained in complete remission for over 7 years. Conclusion: This is the first report of a case of metastatic anal SCC that has been cured with chemotherapy and highlights the need to remain optimistic when treating patients with “palliative” chemotherapy.

Share and Cite:

Haydon, A. , Tay, R. , Mak, G. and Shapiro, J. (2015) Long Survival (Cure) to Cisplatin/Infusional 5-Flurouracil in Metastatic Squamous Cell Anal Cancer with Extensive Liver and Lung Metastases. Case Reports in Clinical Medicine, 4, 73-76. doi: 10.4236/crcm.2015.43017.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Siegel, R.L., Miller, K.D. and Jemal, A. (2015) Cancer Statistics. CA: A Cancer Journal for Clinicians, 65, 5-29.
[2] Yhim, H., Lee, R.N., Song, E.K., Kwak, J.Y., Lee, S.T., et al. (2011) The Prognostic Significance of Tumor Human Papillomavirus Status for Patients with Anal Squamous Cell Carcinoma Treated with Combined Chemoradiotherapy. International Journal of Cancer, 129, 1752-1760.
[3] Jhawer, M., Mani, S., Lefkopoulous, M., Hahn, R.G., Harris, J., et al. (2006) Phase II Study of Mitomycin-C, Adriamycin, Cisplatin (MAP) and Bleomycin-CCNU in Patients with Advanced Cancer of the Anal Canal: An Eastern Cooperative Oncology Group Study E7282. Investigational New Drugs, 24, 447-454.
[4] Tanum, G. (1993) Treatment of Relapsing Anal Carcinoma. Acta Oncologica, 32, 33-35.
[5] Ajani, J.A., Carrasco, C.H., Jackson, D.E. and Wallace, S. (1989) Combination of Cisplatin Plus Fluoropyrimidine Chemotherapy Effective against Liver Metastases from Carcinoma of the Anal Canal. The American Journal of Medicine, 87, 221-224.
[6] Khater, R., Frenay, M., Bourry, J., Milano, G. and Namer, M. (1986) Cisplatin Plus 5-Fluorouracil in the Treatment of Metastatic anal Squamous Cell Carcinoma: A Report of Two Cases. Cancer Treatment Reports, 70, 1345-1346.
[7] Faivre, C., Rougier, P., Ducreux, M., Mitry, E., Lusinchi, A., et al. (1999) 5-Fluorouracile and Cisplatinum Combination Chemotherapy for Metastatic Squamous-Cell Anal Cancer. Bull Cancer, 86, 861-865.
[8] Saif, M., Kontny, E., Syrigos, K.N. and Shahrokni, A. (2011) The Role of EGFR Inhibitors in the Treatment of Metastatic Anal Canal Carcinoma: A Case Series. Journal of Oncology, 125467.
[9] Lukan, N., Strobel, P., Willer, A., Kripp, M., Dinter, D., et al. (2009) Cetuximab-Based Treatment of Metastatic Anal Cancer: Correlation of Response with KRAS Mutational Status. Oncology, 77, 293-299.
[10] Evan, T., Mansi, J. and Glees, J. (1993) Response of Metastatic Anal Carcinoma to Single Agent Carboplatin. Clinical Oncology, 5, 57-58.
[11] Grifaichi, F., Padovani, A., Pomeo, F., Trinca, C., Moscetti, L. and Cortesi, E. (2001) Response of Metastatic Epidermoid Anal Cancer to Single Agent Irinotecan: A Case Report. Tumori, 87, 58-59.

Copyright © 2022 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.